Many of these stocks proved resilient during last week's stock market correction, such as GW Pharmaceuticals Inc. (Nasdaq: GWPH), Scotts Miracle-Gro Co. (NYSE: SMG), and Microsoft Corp. (Nasdaq: MSFT).
In fact, the top weed stocks dipped far less than those in more traditional industries.
And their one-day market comeback on Tuesday outpaced anything we saw in autos, retail, or even blue-chip tech.
Days like that remind me of how ridiculous the mid-2017 mainstream media decrees that investors were burned out on pot stocks were. Those folks somehow believed that the excitement was gone and would not return.
So, while the darlings of Wall Street struggled to make back a fraction of their losses, there were significant success stories coming from places like - you guessed it - California's cannabis sector.
The proof points are all right there. This frontier industry keeps making your investment portfolio get fatter and fatter.
I'm looking at thousands of mini catalysts coming your way.
Let me show you...[mmpazkzone name="in-story" network="9794" site="307044" id="137008" type="4"]
This Is a Huge Sign That California's Weed Market Is Maturing
Jan. 1 marked the opening of what will be the largest state recreational cannabis market in the country: California.
It's already generating millions in revenue.
You see, only about 100 temporary licenses were in place as pot prohibition died in California, which itself boasts an economy larger than all but five countries in the world.
And as the International Cannabis Business Conference (ICBC) got underway last week in San Francisco, the number of licensed dispensaries had only doubled - to 200.
Pot Stock Profits: A historic event is unfolding in California's marijuana markets, and the wealth expected to flow into this industry is record-breaking. Learn how to cash in here...
That's why my team and I caught up with Lori Ajax, the state of California's first "Cannabis Czar," at the ICBC. We wanted to find out what's up - that is, why state and local authorities had granted so few recreational marijuana licenses.
And she had an answer we liked...
Ajax told us that there are a flood of applications still coming in, with new approvals happening almost daily.
And get this...
She expects the number of licensees to reach 2,500 by year's end.
And three times more potential licensees than that have reviewed the application process... indicating that thousands more are watching to see how The Golden State's legalization phase-in goes.
Imagine it... the program is already raking in millions of dollars even before Los Angeles, the nation's second-largest city, was home to even a single licensed dispensary.
Trending: Many are wondering which crypto to buy. America's No. 1 Pattern Trader says this coin could make you very rich. Click here now to learn more.
Overall, we can almost be certain that the number of legal weed dispensaries will increase by at least tenfold in the coming months.
And that's a conservative estimate.
"One of the biggest 'wins' is that we're not giving out licenses in L.A.," said Ajax, who serves as chief of the State of California Bureau of Medical Cannabis Regulation. "That's huge."
That means every new license given out in the coming months, weeks, or even days is a mini-catalyst - a tiny profit "trigger." Beyond that, every California county or city that opens its doors to recreational cannabis is an even bigger profit trigger.
And they're going to keep on coming in The Golden State.
"We're seeing things change every week, every day," said Alex Traverso, an executive at the State of California Bureau of Cannabis Control (BCC). "Every time some municipality comes online, it's a fresh batch of applications."
You can see the wild excitement front and center among all the legal weed entrepreneurs at the ICBC and on social media, where dozens of cannabis business operators are tweeting out pictures of their freshly obtained licenses. You can see some of them linked to on the BCC Twitter feed.
Consider each a mini-catalyst for your California pot stock explosion stocks - and any other cannabis investments you've made.
These licenses are a huge potential profit catalyst for weed stocks... and an opportunity for you folks who got in on the ground floor of pot stock investing when I introduced my 30-stock Roadmap to Marijuana Millions model portfolio in September 2016. Click here...
Follow Michael on Facebook and Twitter.
About the Author
Michael A. Robinson is a 36-year Silicon Valley veteran and one of the top tech and biotech financial analysts working today. That's because, as a consultant, senior adviser, and board member for Silicon Valley venture capital firms, Michael enjoys privileged access to pioneering CEOs, scientists, and high-profile players. And he brings this entire world of Silicon Valley "insiders" right to you...
- He was one of five people involved in early meetings for the $160 billion "cloud" computing phenomenon.
- He was there as Lee Iacocca and Roger Smith, the CEOs of Chrysler and GM, led the robotics revolution that saved the U.S. automotive industry.
- As cyber-security was becoming a focus of national security, Michael was with Dave DeWalt, the CEO of McAfee, right before Intel acquired his company for $7.8 billion.
This all means the entire world is constantly seeking Michael's insight.
In addition to being a regular guest and panelist on CNBC and Fox Business, he is also a Pulitzer Prize-nominated writer and reporter. His first book Overdrawn: The Bailout of American Savings warned people about the coming financial collapse - years before the word "bailout" became a household word.
Silicon Valley defense publications vie for his analysis. He's worked for Defense Media Network and Signal Magazine, as well as The New York Times, American Enterprise, and The Wall Street Journal.
And even with decades of experience, Michael believes there has never been a moment in time quite like this.
Right now, medical breakthroughs that once took years to develop are moving at a record speed. And that means we are going to see highly lucrative biotech investment opportunities come in fast and furious.
To help you navigate the historic opportunity in biotech, Michael launched the Bio-Tech Profit Alliance.
His other publications include: Strategic Tech Investor, The Nova-X Report, Bio-Technology Profit Alliance and Nexus-9 Network.